DLK1 antibodies and methods of treating cancer

CN119486755APending Publication Date: 2025-02-18RGT UNIV OF CALIFORNIA
View PDF 57 Cites 0 Cited by

Patent Information

Application Number
CN202280091022.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2021-12-07
Filing Date
2022-12-07
Publication Date
2025-02-18

Smart Images

  • Figure BDA0004979932000000141
    Figure BDA0004979932000000141
  • Figure BDA0004979932000000151
    Figure BDA0004979932000000151
  • Figure BDA0004979932000000152
    Figure BDA0004979932000000152
Patent Text Reader

Abstract

The present disclosure provides antigen binding proteins that bind to DLK1; a bispecific antigen binding protein that binds to DLK1 and a second antigen; and conjugates thereof. Also provided herein are related polypeptides, nucleic acids, vectors, host cells, and conjugates. In addition, kits and pharmaceutical compositions comprising these entities are also provided. Methods of making the antigen binding proteins and methods of treating subjects having cancer are also provided.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • 7-Substituted camptothecin derivatives and process for their preparation

    EP0056692A1

  • Camptothecin derivatives, processes for preparing same, formulations containing such derivatives and their use

    EP0074256A1

  • Camptothecin-1-oxide derivatives, process for preparing same, formulations comprising said derivatives and said derivatives for use in producing an anti-tumour effect

    EP0074770A1

  • New camptothecin derivatives and process for their preparation

    EP0088642A2

  • New camptothecin derivatives and process for preparing same

    EP0137145A1